Health

Thyroid Tablets Recalled Over Potential Superpotency

Updated 2026-08-25 16:40 UTC 1 source Negative

The FDA has recalled thyroid tablets due to potential superpotency. Patients are advised not to stop taking the medication without consulting their healthcare provider.

Coverage timeline — 1 article
The Hill
Patients taking the affected lot are advised not to discontinue use without first consulting their health care provider.
2026-08-25 16:10 UTC
Share: Twitter / X LinkedIn